Leading injection moulder and med-tech manufacturer Boddingtons travels to this year’s Medica Compamed exhibition, demonstrating its award-winning medical device, set to transform bladder cancer diagnosis.
Boddingtons won the Plastics Industry Awards Industrial Design award for the fourth occasion, this year for its work with Cytosystems on a radical new Bladder Cancer detection product – BladderLight® – involving over thirty moulded components.
The full BladderLight® product development story will be on show at Medica Compamed 2019 at the Boddingtons booth in Hall 8, November 18-21.
Medica Compamed has been established for some time as the leading event in the med-tech supply chain world. It provides a visitor footfall of leading OEMs, healthcare and medical manufacturers who are seeking manufacturing suppliers and contractors to the worldwide medical and healthcare industries.
Boddingtons CEO Andy Tibbs says: ‘In terms of recognition and achievement our business is currently enjoying a purple patch; proving our status time and again as one of the world’s leading contractors for medical manufacturing services.’
Boddingtons will use Compamed 2019 to show off its recent successful manufacturing competences in the med-tech sphere. Customers such as Meditech Endoscopy will be present at the Boddingtons booth to help show visitors the design-for-manufacture process at the company.
The recent Cytosystems project success shows that multi-part medical assemblies are a speciality at Boddingtons, as are cutting-edge moulding developments in biosciences and genetics.
Andy Tibbs, notes: ‘Every year sees something different for us at this show. Compamed 2019 will be our fourth successive exhibition and will greatly help us communicate our messages to the Class 1 and 2 medical device communities.’
Tibbs adds: ‘Boddingtons is also in on the ground floor with the new international MDSAP quality approval qualification. We look forward to expanding our global market business via this year’s Compamed exhibition.’
The company’s £4.6m manufacturing facility – incorporating a modular Class 7 cleanroom – was launched by Lord Digby Jones at the end of 2016 and is now undergoing further investment and development. Thanks to customer demand from the international medical industries a 2nd Class 7 cleanroom is currently being built at Boddingtons and will be commissioned in January 2020.
As well as Class 7 cleanroom manufacture, Boddingtons includes all facets of injection moulding from design to packed products; finishing and assembly processes, printing, welding, packing, labelling and finishing.